🇺🇸 Dexycu, 9% Intraocular Suspension in United States

Dexycu, 9% Intraocular Suspension (Dexycu, 9% Intraocular Suspension) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Dexycu, 9% Intraocular Suspension in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dexycu, 9% Intraocular Suspension approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dexycu, 9% Intraocular Suspension in United States?

Silverstein Eye Centers is the originator. The local marketing authorisation holder may differ — check the official source linked above.